PT-141 — 10mg
PT-141 (Bremelanotide) is a synthetic melanocortin analog developed from the peptide Melanotan 2.
Researchers study PT-141 for its interactions with melanocortin receptors—especially MC3R and MC4R—which are involved in neurobiological, behavioral, and signaling pathways.
$89.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is PT-141?
PT-141 (Bremelanotide) is a synthetic melanocortin analog developed from the peptide Melanotan 2.
Researchers study PT-141 for its interactions with melanocortin receptors—especially MC3R and MC4R—which are involved in neurobiological, behavioral, and signaling pathways.
GENIQ supplies PT-141 strictly for laboratory research only. It is not intended for human or animal use.
Peptide Overview
PT-141 is a cyclic heptapeptide commonly used in studies examining central melanocortin pathways.
In laboratory environments, researchers frequently observe how PT-141 may promote changes in:
| • Melanocortin receptor activation (MC3R/MC4R) |
| • Neurochemical signaling pathways |
| • CNS-related receptor binding behavior |
| • Energy-regulation and metabolic signaling models |
| • Stress-response and autonomic pathways |
| • Hormonal and neurotransmitter-linked cascades |
| All findings remain limited to experimental biochemical and neurobiological models. |
All findings remain limited to preclinical and in-vitro experimental environments.
History of PT-141
PT-141 was discovered during research on Melanotan 2 analogs, where scientists observed that certain fragments showed strong CNS-related receptor activity.
Through structural modification and purification, PT-141 emerged as a more selective analog for MC3R and MC4R.
Over time, PT-141 has been used in research involving:
| • Melanocortin receptor binding studies |
| • Hypothalamic and neuroendocrine signaling |
| • Behavioral and autonomic pathways |
| • Hormonal regulation patterns |
| • Central nervous system (CNS) receptor activity |
| It remains a key tool in studies exploring neural melanocortin pathways. |
Peptide Structure
Sequence: Ac-Nle-c(Asp-His-D-Phe-Arg-Trp-Lys)-OH
Certificates of Analysis
PT-141 — 10mg
Research Findings
Studies involving PT-141 commonly explore:
| • Melanocortin receptor behavior: Researchers assess how PT-141 binds to MC3R and MC4R and the resulting intracellular signaling outcomes. |
| • Central signaling pathways: Laboratory models examine neural pathways influenced by melanocortin activation. |
| • Neurochemical regulation: Research investigates biochemical changes associated with neurotransmitter-linked circuits. |
| • Metabolic and hypothalamic signaling: PT-141 is often included in studies related to energy balance and hypothalamus-mediated pathways. |
| • Stress-response models: In vitro and in vivo models evaluate PT-141 under varying environmental or physiological conditions. |
| These findings do not reflect clinical effects and are limited to research settings. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
2. Cone R., et al. “MC3R and MC4R receptor behavior in peptide studies.” Journal of Central Pathway Biology.
3. Neural Peptide Research Institute. “Characterization of PT-141 in neuroendocrine models.”
4. Behavioral Signaling Unit. “Melanocortin analog interactions with CNS signaling pathways.”
FAQ
What type of research is PT-141 used for?
PT-141 is commonly used in studies involving melanocortin receptor activation, neurobiological pathways, energy regulation, and CNS-associated signaling.
Does GENIQ provide a Certificate of Analysis?
Yes. All GENIQ research materials include a COA verifying identity and purity.
Is PT-141 approved for human or veterinary use?
No. PT-141 is not FDA-approved and is not intended for human or animal administration.
Does GENIQ provide instructions on dosing or preparation?
No. GENIQ does not offer reconstitution or dosing guidance of any kind.
Who should handle this compound?
Only qualified researchers within controlled laboratory environments.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
PT-141 (Bremelanotide) is a synthetic melanocortin analog developed from the peptide Melanotan 2.
Researchers study PT-141 for its interactions with melanocortin receptors—especially MC3R and MC4R—which are involved in neurobiological, behavioral, and signaling pathways.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.